Market Overview

UPDATE: Jefferies & Company Reiterates Buy Rating, Lowers PT on Accuray

Share:
Related ARAY
First Patient Treatment with the CyberKnife® M6™ System and the InCise Multileaf Collimator Has Been Completed
Morgan Stanley Goes Over Accuray's Pros And Cons

In a report published Friday, Jefferies & Company reiterated its Buy rating on Accuray (NASDAQ: ARAY), but lowered its price target from $10.00 to $6.50.

Jefferies noted, “Accuray posted preliminary F2Q results well below expectations and drastically reduced its F13 guidance. The reset under new management was expected but the severity was a surprise. Valuation is set to move into distressed territory, unwarranted given that our thesis is delayed but intact. Lowering estimates and PT but maintaining Buy.”

Accuray closed on Thursday at $6.78.

Latest Ratings for ARAY

DateFirmActionFromTo
Jan 2015Northland SecuritiesInitiates Coverage onOutperform
Jun 2014JP MorganUpgradesNeutralOverweight
Mar 2014BTIG ResearchInitiates Coverage onBuy

View More Analyst Ratings for ARAY
View the Latest Analyst Ratings

Posted-In: Jefferies & CompanyAnalyst Color Price Target Analyst Ratings

 

Related Articles (ARAY)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Benzinga PRO content